ArticlePreventive nutrition and food science2025
Anticancer Effects of Tangeretin on Apoptosis Induction and Cell Growth Inhibition through Mediating Reactive Oxygen Species in Endometrial Cancer Cells.
Article in Preventive nutrition and food science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endometrial cancer, the most common gynecologic malignancy, originates within the epithelial lining of the uterus. Although early diagnosis can lead to effective treatment and improved recovery rates, the worldwide incidence and mortality rates of this cancer continue to rise. The prognosis is particularly poor in cases of metastatic or recurrent disease. Tangeretin, a flavonoid found in citrus fruits, is known for its various biological properties, including antioxidant and anti-inflammatory activities. It has demonstrated anticancer effects against a range of cancers, including bladder, colorectal carcinoma, and breast cancer. However, its effects on endometrial cancer cells have not been previously examined. Here, we investigate the effects of tangeretin on cell viability, proliferation, migration, reactive oxygen species (ROS) generation, and apoptosis in Ishikawa cells, a well-characterized epithelial model used in endometrial research. Our results show that tangeretin treatment significantly inhibits the viability and proliferation of Ishikawa cells. In addition, it suppresses cell migration, as evidenced by wound healing assays. The 2',7'-dichlorofluorescein diacetate assay revealed that tangeretin enhances ROS generation. Moreover, an annexin V/propidium iodide assay confirmed that tangeretin induces apoptotic death in Ishikawa cells. The expression of B-cell lymphoma 2-associated X protein was analyzed to validate the induction of apoptosis. These findings suggest that tangeretin exhibits anticancer effects on endometrial cancer cells by inhibiting proliferation and migration while promoting apoptosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.